Evidence map›Paper›PMID 42297464›Full record

ArticleBJU international2026

International Delphi consensus on single-port robotic radical prostatectomy: patient selection, surgical technique, and training.

Nicolas A Soputro, Soroush Rais-Bahrami, Marc Bjurlin, Abhishek Srivastava, Eric Umbreit, Mohamed Eltemamy, Raymond Pak, David G Gelikman, Nicholas Hopson, Albert Geskin and 45 more

Abstract readConsensus Statement
In one paragraph

Article in BJU international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

55 authors.

Nicolas A SoputroGlickman Urological Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0002-5419-0327
Soroush Rais-BahramiWake Forest Atrium Health Baptist, Winston-Salem, NC, USA.
Marc BjurlinUniversity of North Carolina Chapel Hill, Chapel Hill, NC, USA.
Abhishek SrivastavaAtlantic Urology Clinics, Myrtle Beach, SC, USA.
Eric UmbreitUT Health San Antonio, San Antonio, TX, USA.
Mohamed EltemamyGlickman Urological Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0003-2947-179X
Raymond PakMayo Clinic, Jacksonville, FL, USA.
David G GelikmanGlickman Urological Institute, Cleveland Clinic, Cleveland, OH, USA.ORCID 0000-0002-4317-2561
Nicholas HopsonMonument Health, Rapid City, SD, USA.
Albert GeskinSuburban Urology, Pittsburgh, PA, USA.ORCID 0000-0003-3707-9683
Reza MehrazinMount Sinai Hospital, New York, NY, USA.
Maia VandykeUT Southwestern Medical Center, Dallas, TX, USA.
Michael PaleseMount Sinai Hospital, New York, NY, USA.ORCID 0000-0003-0547-8452
Carvell NguyenMetro Health, Cleveland, OH, USA.
David OrnsteinPrecision Healthcare Specialist, Naples, FL, USA.
Mubashir Shabil BillahHackensack University Medical Center, Hackensack, NJ, USA.
Christopher RussellAdvent Health, Orlando, FL, USA.
Bertram YuhCity of Hope, Duarte, CA, USA.
Alan ThongStanford Medicine, Stanford, CA, USA.
Ruben OlivaresGlickman Urological Institute, Cleveland Clinic, Cleveland, OH, USA.
Sugandh ShettyCorewell Health William Beaumont, Royal Oak, MI, USA.
Jaschar Shakuri-RadMon Health, Morgantown, WV, USA.
Angelo BaccalaThomas Jefferson University, Philadelphia, PA, USA.
Thomas OsinskiUniversity of Rochester Medical Center, Rochester, NY, USA.
Giuseppe SimoneRegina Elena National Cancer Institute, Rome, Italy.
Sebastien CrouzetHospices Civils de Lyon, Lyon, France.
David I LeeUniversity of California Irvine, Irvine, CA, USA.
Mark BakerFlorida Urology Partners, Tampa, FL, USA.
Mohammad RamadanSSM Health, Oklahoma, OK, USA.
Agostino MatteiLucerne Cantonal Hospital, Lucerne, Switzerland.
Angelo PorrecaPoliclinico Abano Terme, Abano Terme, Italy.
Mohammad JafriComprehensive Urology, Detroit, MI, USA.
Antonio GalfanoNiguarda Hospital, Milan, Italy.
Richard E LinkBaylor College of Medicine, Houston, TX, USA.ORCID 0000-0001-9019-7633
Po LamAssociated Medical Professionals, Syracuse, NY, USA.
Marklyn JonesUC Health, Highland Ranch, CO, USA.
Jeffrey C BassettHoag Medical Group, Newport Beach, CA, USA.
Gennaro MusiEuropean Institute of Oncology, IRCCS, Milan, Italy.
Zeyad R SchwenGlickman Urological Institute, Cleveland Clinic, Cleveland, OH, USA.
Alp Tuna BeksacGlickman Urological Institute, Cleveland Clinic, Cleveland, OH, USA.
Christopher EdenRoyal Surrey County Hospital, Surrey, UK.
Scott MillerWellstar Health, Atlanta, GA, USA.
Paolo GonteroUniversity of Turin, Turin, Italy.
Daniele AmparoreUniversity of Turin, Turin, Italy.
Francesco PorpigliaUniversity of Turin, Turin, Italy.
Srinivas VourgantiRUSH University Medical Center, Chicago, IL, USA.
Mutahar AhmedHackensack University Medical Center, Hackensack, NJ, USA.
Francesco MontorsiSan Raffaele Hospital, Milan, Italy.
Sisto PerdonaIntituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
Alessandro IzzoIntituto Nazionale Tumori Fondazione Pascale, Naples, Italy.
Michael D StifelmanHackensack University Medical Center, Hackensack, NJ, USA.
Simone CrivellaroUniversity of Illinois Chicago (UIC), Chicago, IL, USA.
Alberto BrigantiSan Raffaele Hospital, Milan, Italy.
Jihad KaoukGlickman Urological Institute, Cleveland Clinic, Cleveland, OH, USA.
Riccardo AutorinoGlickman Urological Institute, Cleveland Clinic, Cleveland, OH, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe introduction of the purpose-built single-port (SP) robotic platform has allowed for the advent of regionalized minimally invasive surgical approaches for robotic radical prostatectomy (RARP), including the extraperitoneal and transvesical techniques. This study sought to develop a best practice consensus on the key principles, patient selection, surgical techniques, expected clinical outcomes, and learning curves pertaining to SP-RARP.

methodsA modified Delphi consensus was developed by a panel of experts, consisting of a 33-item questionnaire, with each statement rated using a binary Likert scale ('agree' or 'disagree'). The survey was distributed via email to all practicing SP-RARP surgeons across the USA and Europe. Consensus was defined as ≥75% agreement on a given statement.

resultsA total of 53 surgeons participated in the Delphi Consensus across the two rounds. Of 33 statements, 28 (84.8%) reached agreement in the first round. The remaining consensus was achieved in the second round, involving 35 surgeons, and with one additional statement. The panel agreed that, although are no absolute contraindications to SP-RARP, the preference towards specific SP-RARP techniques should remain guided by the individual patients and surgical expertise. Although the SP extraperitoneal technique is recommended to pursue pelvic lymph node dissections, the panel agreed that transvesical SP-RARP showed promise in promoting shorter hospital stay, faster recovery of urinary continence, and utility in patients with extensive prior abdominal surgery. Consensus was also reached on the need for a structured training pathway, with most recommending beginning with extraperitoneal SP-RARP before advancing to the transvesical approach.

conclusionThis Delphi consensus demonstrates broad agreement among experienced SP surgeons in the USA and Europe, forming the foundation for future research on the clinical utility and necessary training pathways for SP-RARP. Nevertheless, empirical validation based on clinical data from large cohort studies remains important.

Indexed as

Patient SelectionProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresDelphi TechniqueHumansMaleMinimally Invasive Surgeryprostate cancerradical prostatectomyrobotic surgerysingle port

Identifiers

PMID42297464
PMCPMC13458633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.